查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1957491

2026年全球神经再生疗法市场报告

Neuroregeneration Therapy Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，神经再生疗法的市场规模迅速扩张。预计该市场规模将从2025年的112.9亿美元成长到2026年的127.5亿美元，复合年增长率（CAGR）为12.9%。过去几年成长要素包括：神经再生疗法的普及程度有限、神经退化性疾病的高发生率、神经修復临床研究的增加、人们对神经系统疾病管理的认识不断提高，以及对传统药物治疗的依赖。

预计未来几年神经再生疗法市场将快速成长，到2030年将达到205亿美元，复合年增长率（CAGR）为12.6%。预测期内的成长要素包括：先进干细胞和基因疗法的开发、神经刺激设备应用范围的扩大、人工智慧和数位监测技术在治疗中的应用、政府对神经学研究投入的增加，以及製药和生物技术公司之间合作的加强。预测期内的关键趋势包括：干细胞和基因疗法在神经再生领域的应用日益广泛、神经刺激技术在临床实践中的应用不断扩大、以神经保护为靶点的治疗方法发展迅速、奈米技术和生物材料在药物递送领域的应用不断扩展，以及针对神经退化性疾病的个性化治疗方法的整合。

神经系统疾病盛行率的上升预计将推动神经再生疗法市场的成长。神经系统疾病是指影响大脑、脊髓和周边神经，扰乱正常神经系统功能的疾病。环境毒素是导致此现象增加的因素之一；长期暴露于重金属、杀虫剂和工业化学等污染物会损害神经系统，并增加神经退化性疾病的风险。神经再生疗法透过修復和替换受损的神经细胞和组织来治疗这些疾病，恢復丧失的功能，并促进大脑、脊髓和神经的癒合。这最终可以改善运动功能、感觉功能和整体生活品质。例如，2023年10月，总部位于英国的世界神经病学联合会（WFN，一个由各国神经病学会组成的联盟）报告称，全球超过40%的人口将患有某种形式的神经系统疾病，预计到2050年，这一负担将几乎翻一番。因此，神经系统疾病盛行率的上升正在推动神经再生疗法市场的成长。

社会老化预计也将推动市场成长。在老年人口比例不断上升的社会中，随着医疗保健和生活水准的提高，预期寿命延长，神经功能衰退的风险也随之增加。神经再生疗法透过修復受损的神经细胞、改善大脑功能和运动技能以及延缓认知衰退，最终提高老年人的生活品质。例如，根据英国图书馆2024年7月发布的报告，2022年英国65岁及以上人口约占总人口的19%（约1,270万人），预计到2072年将增加至2,210万人（27%）。因此，人口老化正在推动神经再生疗法市场的成长。

目录

第一章：执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球神经再生疗法市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略适宜性评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 清单：主要原料、资源和供应商
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章：全球市场趋势与策略

  • 关键科技与未来趋势
    • 生物技术、基因组学和精准医疗
    • 数位化、云端运算、巨量资料、网路安全
    • 人工智慧（AI）和自主人工智慧
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施、互联生态系统
  • 主要趋势
    • 干细胞和基因疗法在神经再生的应用日益广泛
    • 扩大神经刺激技术在临床环境的应用
    • 针对神经保护的药物治疗方法的发展
    • 奈米技术和生物材料在药物传递领域的拓展
    • 整合针对神经退化性疾病的个人化治疗方法

第五章 终端用户产业市场分析

  • 医院
  • 临床研究机构
  • 学术机构
  • 製药和生物技术公司
  • 復健中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及 COVID-19 疫情对市场的影响。

第七章：全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球神经再生疗法市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和抑制因素）
  • 全球神经再生疗法市场规模、对比及成长率分析
  • 全球神经再生疗法市场表现：规模与成长，2020-2025年
  • 全球神经再生疗法市场预测：规模与成长，2025-2030年，2035年预测

第八章：全球市场总规模（TAM）

第九章 市场细分

  • 神经再生疗法的类型
  • 干细胞疗法、基因疗法、药物疗法、神经刺激疗法和其他神经再生疗法
  • 透过技术
  • 组织工程、颅脑及脊髓刺激疗法、药物传递奈米技术、生物材料开发
  • 透过行政途径
  • 口服、注射、植入等给药方式
  • 指示
  • 脊髓损伤、创伤性脑损伤、中风、巴金森氏症、多发性硬化症、阿兹海默症、週边神经损伤及其他适应症。
  • 最终用户
  • 医院、临床研究机构、学术机构、製药和生物技术公司
  • 按类型细分：干细胞疗法
  • 胚胎干细胞疗法、间质干细胞疗法、神经干细胞疗法、诱导性多功能细胞疗法、造血干细胞疗法
  • 按类型细分：基因治疗
  • 体内基因治疗、体外基因治疗、以病毒载体为基础的基因治疗、基于非病毒载体的基因治疗、基因组编辑基因治疗
  • 按类型细分：药物治疗
  • 神经保护药物、神经营养因子类药物、抗发炎药物、抗氧化剂
  • 按类型细分：神经刺激疗法
  • 深部脑部刺激、经颅磁刺激、迷走神经刺激、脊髓刺激、经颅直流电刺激
  • 按类型细分：其他神经再生疗法
  • 以奈米技术为基础的疗法、以外泌体为基础的疗法、以生物材料为基础的疗法

第十章 区域与国别分析

  • 全球神经再生疗法市场：按地区划分，实际数据和预测数据，2020-2025年、2025-2030年、2035年
  • 全球神经再生疗法市场：按国家/地区划分，实际数据和预测数据，2020-2025年、2025-2030年、2035年

第十一章 亚太市场

第十二章：中国市场

第十三章：印度市场

第十四章：日本市场

第十五章：澳洲市场

第十六章：印尼市场

第十七章：韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第20章 西欧市场

第21章英国市场

第22章：德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章：东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第三十章：加拿大市场

第31章：南美市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第三十五章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 神经再生疗法市场：竞争格局及市场占有率（2024年）
  • 神经再生疗法市场：公司评估矩阵
  • 神经再生疗法市场：公司概况
    • F. Hoffmann-La Roche Ltd.
    • Merck & Co. Inc.
    • AbbVie Inc.
    • Sanofi SA
    • Novartis International AG

第37章 其他大型企业和创新企业

  • Stryker Corporation, Biogen Inc., Synovis Life Technologies Inc., Integra LifeSciences Holdings Corporation, AxoGen Inc., Denali Therapeutics Inc., Aspen Neuroscience Inc., Neurona Therapeutics Inc., Lineage Cell Therapeutics Inc., Checkpoint Surgical Inc., Stemedica Cell Technologies Inc., Polyganics BV, Epineuron Technologies Inc., NeuExcell Therapeutics Inc

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年神经再生疗法市场：提供新机会的国家
  • 2030年神经再生疗法市场：蕴藏新机会的细分市场
  • 2030年神经再生疗法市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第41章附录

简介目录
Product Code: PH5MNTHE01_G26Q1

Neuroregeneration therapy encompasses medical interventions aimed at repairing, regenerating, or replacing damaged neurons and neural tissues in the brain, spinal cord, or peripheral nerves. Its primary objective is to restore neurological functions that have been lost due to injury, disease, or degenerative disorders.

The main types of neuroregeneration therapy include stem cell therapy, gene therapy, pharmacological therapy, neurostimulation therapy, and other approaches. Stem cell therapy involves the use of stem cells to repair, replace, or regenerate damaged or diseased cells, tissues, or organs. These therapies employ various technologies such as tissue engineering, cranial and spinal stimulation, nanotechnology-based drug delivery, and biomaterials development. They can be administered through multiple routes, including oral, injectable, and implantable methods. Neuroregeneration therapies are applied to a range of indications, including spinal cord injury, traumatic brain injury, stroke, Parkinson's disease, multiple sclerosis, Alzheimer's disease, and peripheral nerve injury. Key end users include hospitals, clinical research institutes, academic institutions, and pharmaceutical and biotechnology companies.

Tariffs have impacted the neuroregeneration therapy market by increasing the cost of imported stem cell products, gene therapy vectors, neurostimulation devices, and biomaterials. Segments such as stem cell therapy, gene therapy, and advanced neurostimulation are most affected, particularly in North America, Europe, and Asia-Pacific regions reliant on imports. This has resulted in higher therapy costs and slowed adoption in some regions. However, tariffs have also encouraged domestic production, innovation in neuroregeneration technologies, and investment in local manufacturing capacities.

The neuroregeneration therapy market research report is one of a series of new reports from The Business Research Company that provides neuroregeneration therapy market statistics, including neuroregeneration therapy industry global market size, regional shares, competitors with a neuroregeneration therapy market share, detailed neuroregeneration therapy market segments, market trends and opportunities, and any further data you may need to thrive in the neuroregeneration therapy industry. This neuroregeneration therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neuroregeneration therapy market size has grown rapidly in recent years. It will grow from $11.29 billion in 2025 to $12.75 billion in 2026 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to limited availability of neuroregeneration therapies, high prevalence of neurodegenerative diseases, growing clinical research on neural repair, rising awareness of neurological disorder management, reliance on conventional pharmacological treatments.

The neuroregeneration therapy market size is expected to see rapid growth in the next few years. It will grow to $20.5 billion in 2030 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to development of advanced stem cell and gene therapies, expansion of neurostimulation device applications, integration of AI and digital monitoring in therapy, increasing government funding for neurological research, rising collaborations between pharma and biotech companies. Major trends in the forecast period include rising adoption of stem cell and gene therapies for neuroregeneration, increasing use of neurostimulation techniques in clinical practice, growth in pharmacological therapies targeting neuroprotection, expansion of nanotechnology and biomaterials in drug delivery, integration of personalized therapy approaches for neurodegenerative disorders.

The rising prevalence of neurological disorders is expected to propel the growth of the neuroregeneration therapy market going forward. Neurological disorders are conditions that affect the brain, spinal cord, or peripheral nerves, disrupting normal nervous system function. This increase is partly due to environmental toxins, as chronic exposure to pollutants such as heavy metals, pesticides, and industrial chemicals can damage the nervous system and elevate the risk of neurodegenerative diseases. Neuroregeneration therapy addresses these disorders by repairing or replacing damaged neurons and tissues, restoring lost functions and promoting healing in the brain, spinal cord, or nerves, thereby improving mobility, sensation, and overall quality of life. For instance, in October 2023, the World Federation of Neurology, a UK-based association of national neurological societies, reported that more than 40% of the global population experiences some form of neurological condition, with this burden expected to nearly double by 2050. Therefore, the rising prevalence of neurological disorders is driving the growth of the neuroregeneration therapy market.

The growing aging population is also expected to fuel market growth. Aging populations, defined by an increasing proportion of elderly individuals in society, face higher risks of neurological decline due to longer life expectancy from improved healthcare and living standards. Neuroregeneration therapy benefits this demographic by repairing damaged nerve cells, enhancing brain function and mobility, and slowing cognitive decline, ultimately improving quality of life. For instance, in July 2024, the House of Commons Library reported that in 2022, individuals aged 65 and over represented approximately 19% of the UK population (around 12.7 million), projected to grow to 22.1 million (27%) by 2072. Therefore, the rising aging population is driving the growth of the neuroregeneration therapy market.

Major companies in the neuroregeneration therapy market are focusing on innovative solutions, such as 3D-printed regenerative medical implants, which provide advanced treatment options for nerve repair and functional recovery. These implants use patient-specific biomaterials and tissue-engineered scaffolds to guide axonal growth, offering improved outcomes compared with traditional autografts or synthetic conduits limited by donor tissue availability and less customizable designs. For instance, in June 2025, 3D Systems Inc., a US-based 3D printing and medical technology company, introduced a peripheral nerve implant to facilitate targeted neuroregeneration. The implant is composed of biocompatible, 3D-printed scaffolds engineered to guide nerve regrowth, providing structural and biochemical cues that promote axonal extension and reconnection. Its unique features include patient-specific customization, integration with surrounding tissue, and compatibility with peripheral nerve repair procedures. Applications include peripheral nerve injury repair, functional restoration after trauma or surgery, and neuroregenerative research, with benefits such as accelerated recovery, improved functional outcomes, and reduced dependence on donor grafts.

Major companies operating in the neuroregeneration therapy market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Novartis International AG, Stryker Corporation, Biogen Inc., Synovis Life Technologies Inc., Integra LifeSciences Holdings Corporation, AxoGen Inc., Denali Therapeutics Inc., Aspen Neuroscience Inc., Neurona Therapeutics Inc., Lineage Cell Therapeutics Inc., Checkpoint Surgical Inc., Stemedica Cell Technologies Inc., Polyganics B.V., Epineuron Technologies Inc., NeuExcell Therapeutics Inc.

North America was the largest region in the neuroregeneration therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neuroregeneration therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neuroregeneration therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neuroregeneration therapy market consists of revenues earned by entities by providing services such as biomaterial implantation services, surgical interventions for nerve repair, and consulting and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The neuroregeneration therapy market also includes sales of biomaterials, neurostimulation and neuromodulation devices, pharmaceuticals, and neural electrode arrays. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neuroregeneration Therapy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses neuroregeneration therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neuroregeneration therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neuroregeneration therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type Of Neuroregeneration Therapy: Stem Cell Therapy; Gene Therapy; Pharmacological Therapy; Neurostimulation Therapy; Other Types Of Neuroregeneration Therapy
  • 2) By Technology: Tissue Engineering; Cranial And Spinal Stimulation; Nanotechnology In Drug Delivery; Biomaterials Development
  • 3) By Mode Of Administration: Oral; Injectable; Implantable; Other Modes Of Administration
  • 4) By Indication: Spinal Cord Injury; Traumatic Brain Injury; Stroke; Parkinson's Disease; Multiple Sclerosis; Alzheimer's Disease; Peripheral Nerve Injury; Other Indications
  • 5) By End-User: Hospitals; Clinical Research Institutes; Academic Institutions; Pharmaceutical And Biotechnology Companies
  • Subsegments:
  • 1) By Stem Cell Therapy: Embryonic Stem Cell Therapy; Mesenchymal Stem Cell Therapy; Neural Stem Cell Therapy; Induced Pluripotent Stem Cell Therapy; Hematopoietic Stem Cell Therapy
  • 2) By Gene Therapy: In Vivo Gene Therapy; Ex Vivo Gene Therapy; Viral Vector Based Gene Therapy; Non Viral Vector Based Gene Therapy; Genome Editing Gene Therapy
  • 3) By Pharmacological Therapy: Neuroprotective Drugs; Neurotrophic Factor Based Drugs; Anti Inflammatory Drugs; Antioxidant Drugs
  • 4) By Neurostimulation Therapy: Deep Brain Stimulation; Transcranial Magnetic Stimulation; Vagus Nerve Stimulation; Spinal Cord Stimulation; Transcranial Direct Current Stimulation
  • 5) By Other Types Of Neuroregeneration Therapy: Nanotechnology Based Therapy; Exosome Based Therapy; Biomaterial Based Therapy
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc.; Sanofi S.A.; Novartis International AG; Stryker Corporation; Biogen Inc.; Synovis Life Technologies Inc.; Integra LifeSciences Holdings Corporation; AxoGen Inc.; Denali Therapeutics Inc.; Aspen Neuroscience Inc.; Neurona Therapeutics Inc.; Lineage Cell Therapeutics Inc.; Checkpoint Surgical Inc.; Stemedica Cell Technologies Inc.; Polyganics B.V.; Epineuron Technologies Inc.; NeuExcell Therapeutics Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Neuroregeneration Therapy Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Neuroregeneration Therapy Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Neuroregeneration Therapy Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Neuroregeneration Therapy Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Stem Cell And Gene Therapies For Neuroregeneration
    • 4.2.2 Increasing Use Of Neurostimulation Techniques In Clinical Practice
    • 4.2.3 Growth In Pharmacological Therapies Targeting Neuroprotection
    • 4.2.4 Expansion Of Nanotechnology And Biomaterials In Drug Delivery
    • 4.2.5 Integration Of Personalized Therapy Approaches For Neurodegenerative Disorders

5. Neuroregeneration Therapy Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinical Research Institutes
  • 5.3 Academic Institutions
  • 5.4 Pharmaceutical And Biotechnology Companies
  • 5.5 Rehabilitation Centers

6. Neuroregeneration Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Neuroregeneration Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Neuroregeneration Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Neuroregeneration Therapy Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Neuroregeneration Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Neuroregeneration Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Neuroregeneration Therapy Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Neuroregeneration Therapy Market Segmentation

  • 9.1. Global Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Stem Cell Therapy, Gene Therapy, Pharmacological Therapy, Neurostimulation Therapy, Other Types Of Neuroregeneration Therapy
  • 9.2. Global Neuroregeneration Therapy Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Tissue Engineering, Cranial And Spinal Stimulation, Nanotechnology In Drug Delivery, Biomaterials Development
  • 9.3. Global Neuroregeneration Therapy Market, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oral, Injectable, Implantable, Other Modes Of Administration
  • 9.4. Global Neuroregeneration Therapy Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Spinal Cord Injury, Traumatic Brain Injury, Stroke, Parkinson's Disease, Multiple Sclerosis, Alzheimer's Disease, Peripheral Nerve Injury, Other Indications
  • 9.5. Global Neuroregeneration Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Clinical Research Institutes, Academic Institutions, Pharmaceutical And Biotechnology Companies
  • 9.6. Global Neuroregeneration Therapy Market, Sub-Segmentation Of Stem Cell Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Embryonic Stem Cell Therapy, Mesenchymal Stem Cell Therapy, Neural Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, Hematopoietic Stem Cell Therapy
  • 9.7. Global Neuroregeneration Therapy Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • In Vivo Gene Therapy, Ex Vivo Gene Therapy, Viral Vector Based Gene Therapy, Non Viral Vector Based Gene Therapy, Genome Editing Gene Therapy
  • 9.8. Global Neuroregeneration Therapy Market, Sub-Segmentation Of Pharmacological Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Neuroprotective Drugs, Neurotrophic Factor Based Drugs, Anti Inflammatory Drugs, Antioxidant Drugs
  • 9.9. Global Neuroregeneration Therapy Market, Sub-Segmentation Of Neurostimulation Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Deep Brain Stimulation, Transcranial Magnetic Stimulation, Vagus Nerve Stimulation, Spinal Cord Stimulation, Transcranial Direct Current Stimulation
  • 9.10. Global Neuroregeneration Therapy Market, Sub-Segmentation Of Other Types Of Neuroregeneration Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Nanotechnology Based Therapy, Exosome Based Therapy, Biomaterial Based Therapy

10. Neuroregeneration Therapy Market Regional And Country Analysis

  • 10.1. Global Neuroregeneration Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Neuroregeneration Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Neuroregeneration Therapy Market

  • 11.1. Asia-Pacific Neuroregeneration Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Neuroregeneration Therapy Market

  • 12.1. China Neuroregeneration Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Neuroregeneration Therapy Market

  • 13.1. India Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Neuroregeneration Therapy Market

  • 14.1. Japan Neuroregeneration Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Neuroregeneration Therapy Market

  • 15.1. Australia Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Neuroregeneration Therapy Market

  • 16.1. Indonesia Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Neuroregeneration Therapy Market

  • 17.1. South Korea Neuroregeneration Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Neuroregeneration Therapy Market

  • 18.1. Taiwan Neuroregeneration Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Neuroregeneration Therapy Market

  • 19.1. South East Asia Neuroregeneration Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Neuroregeneration Therapy Market

  • 20.1. Western Europe Neuroregeneration Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Neuroregeneration Therapy Market

  • 21.1. UK Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Neuroregeneration Therapy Market

  • 22.1. Germany Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Neuroregeneration Therapy Market

  • 23.1. France Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Neuroregeneration Therapy Market

  • 24.1. Italy Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Neuroregeneration Therapy Market

  • 25.1. Spain Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Neuroregeneration Therapy Market

  • 26.1. Eastern Europe Neuroregeneration Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Neuroregeneration Therapy Market

  • 27.1. Russia Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Neuroregeneration Therapy Market

  • 28.1. North America Neuroregeneration Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Neuroregeneration Therapy Market

  • 29.1. USA Neuroregeneration Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Neuroregeneration Therapy Market

  • 30.1. Canada Neuroregeneration Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Neuroregeneration Therapy Market

  • 31.1. South America Neuroregeneration Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Neuroregeneration Therapy Market

  • 32.1. Brazil Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Neuroregeneration Therapy Market

  • 33.1. Middle East Neuroregeneration Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Neuroregeneration Therapy Market

  • 34.1. Africa Neuroregeneration Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Neuroregeneration Therapy Market, Segmentation By Type Of Neuroregeneration Therapy, Segmentation By Technology, Segmentation By Mode Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Neuroregeneration Therapy Market Regulatory and Investment Landscape

36. Neuroregeneration Therapy Market Competitive Landscape And Company Profiles

  • 36.1. Neuroregeneration Therapy Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Neuroregeneration Therapy Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Neuroregeneration Therapy Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

37. Neuroregeneration Therapy Market Other Major And Innovative Companies

  • Stryker Corporation, Biogen Inc., Synovis Life Technologies Inc., Integra LifeSciences Holdings Corporation, AxoGen Inc., Denali Therapeutics Inc., Aspen Neuroscience Inc., Neurona Therapeutics Inc., Lineage Cell Therapeutics Inc., Checkpoint Surgical Inc., Stemedica Cell Technologies Inc., Polyganics B.V., Epineuron Technologies Inc., NeuExcell Therapeutics Inc

38. Global Neuroregeneration Therapy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Neuroregeneration Therapy Market

40. Neuroregeneration Therapy Market High Potential Countries, Segments and Strategies

  • 40.1 Neuroregeneration Therapy Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Neuroregeneration Therapy Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Neuroregeneration Therapy Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer